Brind.

Incyte presented data at a congress held in Berlin, Europe on July 25, 2025.

2 reports, 1 independent Updated Jul 17

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Incyte presented data at a congress held in Berlin, Europe on July 25, 2025.

Who's involved

What this event is mainly about

Incyte Europe

Keep exploring

The entities involved

Incyte
American pharmaceutical company
- Incyte, a biotech company based in Wilmington, outperformed the biotech ETF.Thu 13:11
Europe
terrestrial continent located in north-western Eurasia
- The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
- The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49

Related events

Coverage

Newest first; wire copies grouped

Jul 25Business WireIncyte To Present Initial Data for its TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and its Selective Inhibitor of G12D-mutated KRAS (INCB161734) at the European Society of Medical Oncology (E

1 more outlet ran the same wire story

Jul 17finanznachrichten.de